Low serum anti-Müllerian hormone is associated with semen quality in infertile men and not influenced by vitamin D supplementation

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Low serum anti-Müllerian hormone is associated with semen quality in infertile men and not influenced by vitamin D supplementation. / Holt, Rune; Yahyavi, Sam Kafai; Kooij, Ireen; Andreassen, Christine Hjorth; Andersson, Anna Maria; Juul, Anders; Jørgensen, Niels; Blomberg Jensen, Martin.

In: BMC Medicine, Vol. 21, No. 1, 79, 2023.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Holt, R, Yahyavi, SK, Kooij, I, Andreassen, CH, Andersson, AM, Juul, A, Jørgensen, N & Blomberg Jensen, M 2023, 'Low serum anti-Müllerian hormone is associated with semen quality in infertile men and not influenced by vitamin D supplementation', BMC Medicine, vol. 21, no. 1, 79. https://doi.org/10.1186/s12916-023-02782-1

APA

Holt, R., Yahyavi, S. K., Kooij, I., Andreassen, C. H., Andersson, A. M., Juul, A., Jørgensen, N., & Blomberg Jensen, M. (2023). Low serum anti-Müllerian hormone is associated with semen quality in infertile men and not influenced by vitamin D supplementation. BMC Medicine, 21(1), [79]. https://doi.org/10.1186/s12916-023-02782-1

Vancouver

Holt R, Yahyavi SK, Kooij I, Andreassen CH, Andersson AM, Juul A et al. Low serum anti-Müllerian hormone is associated with semen quality in infertile men and not influenced by vitamin D supplementation. BMC Medicine. 2023;21(1). 79. https://doi.org/10.1186/s12916-023-02782-1

Author

Holt, Rune ; Yahyavi, Sam Kafai ; Kooij, Ireen ; Andreassen, Christine Hjorth ; Andersson, Anna Maria ; Juul, Anders ; Jørgensen, Niels ; Blomberg Jensen, Martin. / Low serum anti-Müllerian hormone is associated with semen quality in infertile men and not influenced by vitamin D supplementation. In: BMC Medicine. 2023 ; Vol. 21, No. 1.

Bibtex

@article{a6581c3542b649148ce19a4b538ecd21,
title = "Low serum anti-M{\"u}llerian hormone is associated with semen quality in infertile men and not influenced by vitamin D supplementation",
abstract = "Background: Anti-M{\"u}llerian hormone (AMH) is released by testicular Sertoli cells and of great importance during fetal male sexual development, but less is known about the role of circulating AMH during adulthood. In vitro studies have shown that vitamin D may induce AMH transcription, but a controlled trial investigating the possible effect of vitamin D on serum AMH has not been conducted in men. Methods: A single-center, double-blinded, randomized placebo-controlled clinical trial (NCT01304927) conducted in Copenhagen, Denmark. A total of 307 infertile men were included and randomly assigned (1:1) to a single dose of 300,000 IU cholecalciferol followed by 1400 IU cholecalciferol + 500 mg of calcium daily (n = 151) or placebo (n = 156) for 150 days. Difference in serum AMH was a predefined secondary endpoint. Explorative outcomes were associations between serum AMH and gonadal function in infertile men. The primary endpoint was difference in semen quality and has previously been published. Results: Infertile men in the lowest AMH tertile had significantly lower sperm concentration (∆T3-1 16 mill/mL (228%); P < 0.001), sperm count (∆T3-1 55 million (262%); P < 0.001), motile sperm count (∆T3-1 28 million (255%); P < 0.001), progressive motile sperm count (∆T3-1 18 million (300%); P < 0.001), testis size (∆T3-1 2.7 mL (16%); P < 0.001), serum inhibin B (∆T3-1 72 pg/mL (59%); P < 0.001), inhibin B/FSH ratio (∆T3-1 48 (145%); P < 0.001), and higher FSH (∆T3-1 2.6 (38%); P < 0.001) than the tertile of infertile men with highest serum AMH. Vitamin D supplementation had no effect on serum AMH compared with placebo treatment. Conclusions: In infertile men, low serum AMH is associated with severely impaired gonadal function illustrated by poor semen quality and lower testosterone/LH ratio. Serum AMH in infertile men was not influenced by vitamin D supplementation.",
keywords = "AMH, Citamin D, Male infertility, Semen quality, Sertoli cell function",
author = "Rune Holt and Yahyavi, {Sam Kafai} and Ireen Kooij and Andreassen, {Christine Hjorth} and Andersson, {Anna Maria} and Anders Juul and Niels J{\o}rgensen and {Blomberg Jensen}, Martin",
note = "Publisher Copyright: {\textcopyright} 2023, The Author(s).",
year = "2023",
doi = "10.1186/s12916-023-02782-1",
language = "English",
volume = "21",
journal = "BMC Medicine",
issn = "1741-7015",
publisher = "BioMed Central Ltd.",
number = "1",

}

RIS

TY - JOUR

T1 - Low serum anti-Müllerian hormone is associated with semen quality in infertile men and not influenced by vitamin D supplementation

AU - Holt, Rune

AU - Yahyavi, Sam Kafai

AU - Kooij, Ireen

AU - Andreassen, Christine Hjorth

AU - Andersson, Anna Maria

AU - Juul, Anders

AU - Jørgensen, Niels

AU - Blomberg Jensen, Martin

N1 - Publisher Copyright: © 2023, The Author(s).

PY - 2023

Y1 - 2023

N2 - Background: Anti-Müllerian hormone (AMH) is released by testicular Sertoli cells and of great importance during fetal male sexual development, but less is known about the role of circulating AMH during adulthood. In vitro studies have shown that vitamin D may induce AMH transcription, but a controlled trial investigating the possible effect of vitamin D on serum AMH has not been conducted in men. Methods: A single-center, double-blinded, randomized placebo-controlled clinical trial (NCT01304927) conducted in Copenhagen, Denmark. A total of 307 infertile men were included and randomly assigned (1:1) to a single dose of 300,000 IU cholecalciferol followed by 1400 IU cholecalciferol + 500 mg of calcium daily (n = 151) or placebo (n = 156) for 150 days. Difference in serum AMH was a predefined secondary endpoint. Explorative outcomes were associations between serum AMH and gonadal function in infertile men. The primary endpoint was difference in semen quality and has previously been published. Results: Infertile men in the lowest AMH tertile had significantly lower sperm concentration (∆T3-1 16 mill/mL (228%); P < 0.001), sperm count (∆T3-1 55 million (262%); P < 0.001), motile sperm count (∆T3-1 28 million (255%); P < 0.001), progressive motile sperm count (∆T3-1 18 million (300%); P < 0.001), testis size (∆T3-1 2.7 mL (16%); P < 0.001), serum inhibin B (∆T3-1 72 pg/mL (59%); P < 0.001), inhibin B/FSH ratio (∆T3-1 48 (145%); P < 0.001), and higher FSH (∆T3-1 2.6 (38%); P < 0.001) than the tertile of infertile men with highest serum AMH. Vitamin D supplementation had no effect on serum AMH compared with placebo treatment. Conclusions: In infertile men, low serum AMH is associated with severely impaired gonadal function illustrated by poor semen quality and lower testosterone/LH ratio. Serum AMH in infertile men was not influenced by vitamin D supplementation.

AB - Background: Anti-Müllerian hormone (AMH) is released by testicular Sertoli cells and of great importance during fetal male sexual development, but less is known about the role of circulating AMH during adulthood. In vitro studies have shown that vitamin D may induce AMH transcription, but a controlled trial investigating the possible effect of vitamin D on serum AMH has not been conducted in men. Methods: A single-center, double-blinded, randomized placebo-controlled clinical trial (NCT01304927) conducted in Copenhagen, Denmark. A total of 307 infertile men were included and randomly assigned (1:1) to a single dose of 300,000 IU cholecalciferol followed by 1400 IU cholecalciferol + 500 mg of calcium daily (n = 151) or placebo (n = 156) for 150 days. Difference in serum AMH was a predefined secondary endpoint. Explorative outcomes were associations between serum AMH and gonadal function in infertile men. The primary endpoint was difference in semen quality and has previously been published. Results: Infertile men in the lowest AMH tertile had significantly lower sperm concentration (∆T3-1 16 mill/mL (228%); P < 0.001), sperm count (∆T3-1 55 million (262%); P < 0.001), motile sperm count (∆T3-1 28 million (255%); P < 0.001), progressive motile sperm count (∆T3-1 18 million (300%); P < 0.001), testis size (∆T3-1 2.7 mL (16%); P < 0.001), serum inhibin B (∆T3-1 72 pg/mL (59%); P < 0.001), inhibin B/FSH ratio (∆T3-1 48 (145%); P < 0.001), and higher FSH (∆T3-1 2.6 (38%); P < 0.001) than the tertile of infertile men with highest serum AMH. Vitamin D supplementation had no effect on serum AMH compared with placebo treatment. Conclusions: In infertile men, low serum AMH is associated with severely impaired gonadal function illustrated by poor semen quality and lower testosterone/LH ratio. Serum AMH in infertile men was not influenced by vitamin D supplementation.

KW - AMH

KW - Citamin D

KW - Male infertility

KW - Semen quality

KW - Sertoli cell function

U2 - 10.1186/s12916-023-02782-1

DO - 10.1186/s12916-023-02782-1

M3 - Journal article

C2 - 36855109

AN - SCOPUS:85149153021

VL - 21

JO - BMC Medicine

JF - BMC Medicine

SN - 1741-7015

IS - 1

M1 - 79

ER -

ID: 341276874